{"entity":{"type":"insider","cik":"0001357522","url":"/insider/0001357522","json_url":"/insider/0001357522.json","name":"Thompson Peter A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":111,"n_filings":55,"first":"2006-10-19","last":"2026-07-09","span_basis":"filed_date"},"name_variants":[{"name":"Thompson Peter A.","source":"filing","n_filings":53,"first_seen":"2015-07-21","last_seen":"2026-07-09"},{"name":"Thompson Peter A","source":"filing","n_filings":2,"first_seen":"2006-10-19","last_seen":"2007-11-20"}],"transactions":[{"id":5868802,"accession":"0000947871-26-000695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000695","line_url":"/filing/0000947871-26-000695#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85918.0,"shares_display":"85,918","price_per_share":44.86,"price_display":"44.86","price_state":"stated","total_value":3854281.48,"total_display":"3,854,281.48","total_whole":"3,854,281","shares_owned_after":2469959.0,"shares_owned_after_display":"2,469,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-09","scope":"insider"},{"id":6217414,"accession":"0000947871-26-000684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000684","line_url":"/filing/0000947871-26-000684#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115844.0,"shares_display":"115,844","price_per_share":45.5,"price_display":"45.50","price_state":"stated","total_value":5270902.0,"total_display":"5,270,902.00","total_whole":"5,270,902","shares_owned_after":2555877.0,"shares_owned_after_display":"2,555,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-02","scope":"insider"},{"id":5832481,"accession":"0000947871-26-000588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000588","line_url":"/filing/0000947871-26-000588#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":4493.49,"total_display":"4,493.49","total_whole":"4,493","shares_owned_after":2671721.0,"shares_owned_after_display":"2,671,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-27","filed_date":"2026-05-29","scope":"insider"},{"id":5879996,"accession":"0000947871-26-000518","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-26-000518","line_url":"/filing/0000947871-26-000518#line-3","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184639.0,"shares_display":"184,639","price_per_share":46.22,"price_display":"46.22","price_state":"stated","total_value":8534014.58,"total_display":"8,534,014.58","total_whole":"8,534,015","shares_owned_after":2671822.0,"shares_owned_after_display":"2,671,822","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-11","scope":"insider"},{"id":5879994,"accession":"0000947871-26-000518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000518","line_url":"/filing/0000947871-26-000518#line-2","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59767.0,"shares_display":"59,767","price_per_share":44.58,"price_display":"44.58","price_state":"stated","total_value":2664412.86,"total_display":"2,664,412.86","total_whole":"2,664,413","shares_owned_after":2856461.0,"shares_owned_after_display":"2,856,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-08","filed_date":"2026-05-11","scope":"insider"},{"id":5879992,"accession":"0000947871-26-000518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000518","line_url":"/filing/0000947871-26-000518#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48546.0,"shares_display":"48,546","price_per_share":44.61,"price_display":"44.61","price_state":"stated","total_value":2165637.06,"total_display":"2,165,637.06","total_whole":"2,165,637","shares_owned_after":2916228.0,"shares_owned_after_display":"2,916,228","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider"},{"id":5817952,"accession":"0000947871-26-000459","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000459","line_url":"/filing/0000947871-26-000459#line-2","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2948.0,"shares_display":"2,948","price_per_share":44.52,"price_display":"44.52","price_state":"stated","total_value":131244.96,"total_display":"131,244.96","total_whole":"131,245","shares_owned_after":2964774.0,"shares_owned_after_display":"2,964,774","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-18","filed_date":"2026-04-21","scope":"insider"},{"id":5817948,"accession":"0000947871-26-000459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000459","line_url":"/filing/0000947871-26-000459#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52397.0,"shares_display":"52,397","price_per_share":44.68,"price_display":"44.68","price_state":"stated","total_value":2341097.96,"total_display":"2,341,097.96","total_whole":"2,341,098","shares_owned_after":2967722.0,"shares_owned_after_display":"2,967,722","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-21","scope":"insider"},{"id":6164356,"accession":"0000947871-26-000447","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-26-000447","line_url":"/filing/0000947871-26-000447#line-3","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226906.0,"shares_display":"226,906","price_per_share":45.34,"price_display":"45.34","price_state":"stated","total_value":10287918.04,"total_display":"10,287,918.04","total_whole":"10,287,918","shares_owned_after":3020119.0,"shares_owned_after_display":"3,020,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-16","scope":"insider"},{"id":6164353,"accession":"0000947871-26-000447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000447","line_url":"/filing/0000947871-26-000447#line-2","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":235863.0,"shares_display":"235,863","price_per_share":44.64,"price_display":"44.64","price_state":"stated","total_value":10528924.32,"total_display":"10,528,924.32","total_whole":"10,528,924","shares_owned_after":3247025.0,"shares_owned_after_display":"3,247,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-16","scope":"insider"},{"id":6164350,"accession":"0000947871-26-000447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000447","line_url":"/filing/0000947871-26-000447#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47814.0,"shares_display":"47,814","price_per_share":44.51,"price_display":"44.51","price_state":"stated","total_value":2128201.14,"total_display":"2,128,201.14","total_whole":"2,128,201","shares_owned_after":3482888.0,"shares_owned_after_display":"3,482,888","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-14","filed_date":"2026-04-16","scope":"insider"},{"id":6052157,"accession":"0000947871-26-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000089","line_url":"/filing/0000947871-26-000089#line-2","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29063.0,"shares_display":"29,063","price_per_share":44.58,"price_display":"44.58","price_state":"stated","total_value":1295628.54,"total_display":"1,295,628.54","total_whole":"1,295,629","shares_owned_after":3530702.0,"shares_owned_after_display":"3,530,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider"},{"id":6052154,"accession":"0000947871-26-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000089","line_url":"/filing/0000947871-26-000089#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1890.0,"shares_display":"1,890","price_per_share":44.57,"price_display":"44.57","price_state":"stated","total_value":84237.3,"total_display":"84,237.30","total_whole":"84,237","shares_owned_after":3559765.0,"shares_owned_after_display":"3,559,765","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4338760,"accession":"0000947871-25-001095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-001095","line_url":"/filing/0000947871-25-001095#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33356.0,"shares_display":"33,356","price_per_share":44.55,"price_display":"44.55","price_state":"stated","total_value":1486009.8,"total_display":"1,486,009.80","total_whole":"1,486,010","shares_owned_after":3561655.0,"shares_owned_after_display":"3,561,655","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-24","filed_date":"2025-12-29","scope":"insider"},{"id":4939455,"accession":"0000947871-25-001087","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-001087","line_url":"/filing/0000947871-25-001087#line-3","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":38928.75,"total_display":"38,928.75","total_whole":"38,929","shares_owned_after":3595011.0,"shares_owned_after_display":"3,595,011","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-19","scope":"insider"},{"id":4939454,"accession":"0000947871-25-001087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-001087","line_url":"/filing/0000947871-25-001087#line-2","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":4449.0,"total_display":"4,449.00","total_whole":"4,449","shares_owned_after":3595886.0,"shares_owned_after_display":"3,595,886","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-19","scope":"insider"},{"id":4939453,"accession":"0000947871-25-001087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-001087","line_url":"/filing/0000947871-25-001087#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":44.5,"price_display":"44.50","price_state":"stated","total_value":40050.0,"total_display":"40,050.00","total_whole":"40,050","shares_owned_after":3595986.0,"shares_owned_after_display":"3,595,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-19","scope":"insider"},{"id":4831873,"accession":"0000947871-25-001044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-001044","line_url":"/filing/0000947871-25-001044#line-3","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":71184.0,"total_display":"71,184.00","total_whole":"71,184","shares_owned_after":3596886.0,"shares_owned_after_display":"3,596,886","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-11-26","scope":"insider"},{"id":4831869,"accession":"0000947871-25-001044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-001044","line_url":"/filing/0000947871-25-001044#line-2","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11890.0,"shares_display":"11,890","price_per_share":44.6,"price_display":"44.60","price_state":"stated","total_value":530294.0,"total_display":"530,294.00","total_whole":"530,294","shares_owned_after":3598486.0,"shares_owned_after_display":"3,598,486","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4831865,"accession":"0000947871-25-001044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-001044","line_url":"/filing/0000947871-25-001044#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94583.0,"shares_display":"94,583","price_per_share":44.54,"price_display":"44.54","price_state":"stated","total_value":4212726.82,"total_display":"4,212,726.82","total_whole":"4,212,727","shares_owned_after":3610376.0,"shares_owned_after_display":"3,610,376","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4574603,"accession":"0000947871-25-000635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000635","line_url":"/filing/0000947871-25-000635#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Corvus Pharmaceuticals, Inc.","issuer_ticker":"CRVS","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1176332.0,"shares_display":"1,176,332","price_per_share":4.1586,"price_display":"4.16","price_state":"stated","total_value":4891894.2552,"total_display":"4,891,894.26","total_whole":"4,891,894","shares_owned_after":7165006.0,"shares_owned_after_display":"7,165,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider"},{"id":4193191,"accession":"0000947871-25-000360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000360","line_url":"/filing/0000947871-25-000360","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":496771.0,"shares_display":"496,771","price_per_share":20.13,"price_display":"20.13","price_state":"stated","total_value":10000000.23,"total_display":"10,000,000.23","total_whole":"10,000,000","shares_owned_after":14809075.0,"shares_owned_after_display":"14,809,075","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider","n_lines":2},{"id":5073225,"accession":"0000950170-25-017031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-017031","line_url":"/filing/0000950170-25-017031#line-2","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":9900000.0,"total_display":"9,900,000.00","total_whole":"9,900,000","shares_owned_after":3704959.0,"shares_owned_after_display":"3,704,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-10","scope":"insider"},{"id":2847349,"accession":"0000947871-24-000729","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000729","line_url":"/filing/0000947871-24-000729#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83695.0,"shares_display":"83,695","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":1088035.0,"total_display":"1,088,035.00","total_whole":"1,088,035","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-28","scope":"insider"},{"id":2174496,"accession":"0000947871-24-000721","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-24-000721","line_url":"/filing/0000947871-24-000721#line-4","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69500.0,"shares_display":"69,500","price_per_share":13.03,"price_display":"13.03","price_state":"stated","total_value":905585.0,"total_display":"905,585.00","total_whole":"905,585","shares_owned_after":83695.0,"shares_owned_after_display":"83,695","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-23","scope":"insider"},{"id":2174492,"accession":"0000947871-24-000721","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000721","line_url":"/filing/0000947871-24-000721#line-3","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":391482.0,"shares_display":"391,482","price_per_share":12.94,"price_display":"12.94","price_state":"stated","total_value":5065777.08,"total_display":"5,065,777.08","total_whole":"5,065,777","shares_owned_after":153195.0,"shares_owned_after_display":"153,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-23","scope":"insider"},{"id":2174487,"accession":"0000947871-24-000721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000721","line_url":"/filing/0000947871-24-000721","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":407700.0,"shares_display":"407,700","price_per_share":13.555558008339466,"price_display":"13.56","price_state":"stated","total_value":5526601.0,"total_display":"5,526,601.00","total_whole":"5,526,601","shares_owned_after":557977.0,"shares_owned_after_display":"557,977","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider","n_lines":2},{"id":2541682,"accession":"0000947871-24-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000070","line_url":"/filing/0000947871-24-000070#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":454545.0,"shares_display":"454,545","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":14436497.0,"shares_owned_after_display":"14,436,497","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider"},{"id":8192067,"accession":"0000947871-23-001190","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-23-001190","line_url":"/filing/0000947871-23-001190","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1364849.0,"shares_display":"1,364,849","price_per_share":18.352970680273057,"price_display":"18.35","price_state":"stated","total_value":25049033.68,"total_display":"25,049,033.68","total_whole":"25,049,034","shares_owned_after":2270930.0,"shares_owned_after_display":"2,270,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-28","filed_date":"2023-12-29","scope":"insider","n_lines":4},{"id":8192053,"accession":"0000947871-23-001190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-23-001190","line_url":"/filing/0000947871-23-001190","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":181498.0,"shares_display":"181,498","price_per_share":19.96,"price_display":"19.96","price_state":"stated","total_value":3622700.08,"total_display":"3,622,700.08","total_whole":"3,622,700","shares_owned_after":3493485.0,"shares_owned_after_display":"3,493,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider","n_lines":2},{"id":8011307,"accession":"0000947871-23-000914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-23-000914","line_url":"/filing/0000947871-23-000914#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":3100000.0,"total_display":"3,100,000.00","total_whole":"3,100,000","shares_owned_after":8019187.0,"shares_owned_after_display":"8,019,187","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-29","filed_date":"2023-08-31","scope":"insider"},{"id":6805937,"accession":"0000947871-22-000973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-000973","line_url":"/filing/0000947871-22-000973#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":484496.0,"shares_display":"484,496","price_per_share":10.32,"price_display":"10.32","price_state":"stated","total_value":4999998.72,"total_display":"4,999,998.72","total_whole":"4,999,999","shares_owned_after":13981952.0,"shares_owned_after_display":"13,981,952","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-16","scope":"insider"},{"id":6144714,"accession":"0000947871-22-000628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-000628","line_url":"/filing/0000947871-22-000628#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":138000.0,"shares_display":"138,000","price_per_share":7.21,"price_display":"7.21","price_state":"stated","total_value":994980.0,"total_display":"994,980.00","total_whole":"994,980","shares_owned_after":13497456.0,"shares_owned_after_display":"13,497,456","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-20","scope":"insider"},{"id":5492866,"accession":"0000947871-21-001322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-21-001322","line_url":"/filing/0000947871-21-001322","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40400.0,"shares_display":"40,400","price_per_share":20.3,"price_display":"20.30","price_state":"stated","total_value":820120.0,"total_display":"820,120.00","total_whole":"820,120","shares_owned_after":2258566.0,"shares_owned_after_display":"2,258,566","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2021-12-30","scope":"insider","n_lines":2},{"id":4089419,"accession":"0000947871-21-001314","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-21-001314","line_url":"/filing/0000947871-21-001314","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119400.0,"shares_display":"119,400","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":2268600.0,"total_display":"2,268,600.00","total_whole":"2,268,600","shares_owned_after":2295266.0,"shares_owned_after_display":"2,295,266","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-23","scope":"insider","n_lines":2},{"id":4308496,"accession":"0000947871-21-001300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-21-001300","line_url":"/filing/0000947871-21-001300","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":393300.0,"shares_display":"393,300","price_per_share":19.07,"price_display":"19.07","price_state":"stated","total_value":7500231.0,"total_display":"7,500,231.00","total_whole":"7,500,231","shares_owned_after":2403566.0,"shares_owned_after_display":"2,403,566","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-17","scope":"insider","n_lines":2},{"id":4089414,"accession":"0000947871-21-001016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-21-001016","line_url":"/filing/0000947871-21-001016#line-1","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Corvus Pharmaceuticals, Inc.","issuer_ticker":"CRVS","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1109644.0,"shares_display":"1,109,644","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":6757731.96,"total_display":"6,757,731.96","total_whole":"6,757,732","shares_owned_after":6943654.0,"shares_owned_after_display":"6,943,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"},{"id":4566068,"accession":"0000947871-21-001009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-21-001009","line_url":"/filing/0000947871-21-001009","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1010637.0,"shares_display":"1,010,637","price_per_share":9.4,"price_display":"9.40","price_state":"stated","total_value":9499987.8,"total_display":"9,499,987.80","total_whole":"9,499,988","shares_owned_after":3656061.0,"shares_owned_after_display":"3,656,061","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider","n_lines":2},{"id":4377239,"accession":"0001209191-21-041058","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-041058","line_url":"/filing/0001209191-21-041058","is_derivative":false,"issuer_cik":"0001357522","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001357522","owner_cik":"0001357522","owner_name":"Thompson Peter A.","owner_display_name":"Thompson Peter A.","owner_url":"/insider/0001357522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":705853.0,"shares_display":"705,853","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":11999501.0,"total_display":"11,999,501.00","total_whole":"11,999,501","shares_owned_after":2760366.0,"shares_owned_after_display":"2,760,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2021-06-15|4377237","ledger_fault":false,"count":{"value":111,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":64,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":111},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002036042","name":"Sionna Therapeutics, Inc.","url":"/issuer/0002036042","role":"Director","n_filings":11,"first_seen":"2025-02-10","last_seen":"2026-07-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001626971","name":"Corvus Pharmaceuticals, Inc.","url":"/issuer/0001626971","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2016-03-29","last_seen":"2025-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-03-31","last_seen":"2025-04-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2020-12-08","last_seen":"2024-08-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"ALPINE IMMUNE SCIENCES, INC.","url":"/issuer/0001626199","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2019-01-23","last_seen":"2023-12-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001817713","name":"Janux Therapeutics, Inc.","url":"/issuer/0001817713","role":"Director","n_filings":4,"first_seen":"2021-06-16","last_seen":"2021-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001656536","name":"Decibel Therapeutics, Inc.","url":"/issuer/0001656536","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2021-02-19","last_seen":"2021-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-09-29","last_seen":"2020-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001714798","name":"Prevail Therapeutics Inc.","url":"/issuer/0001714798","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2019-06-26","last_seen":"2019-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001609727","name":"Synthorx, Inc.","url":"/issuer/0001609727","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2018-12-13","last_seen":"2018-12-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001621227","name":"Adaptimmune Therapeutics PLC","url":"/issuer/0001621227","role":"Director","n_filings":6,"first_seen":"2016-05-25","last_seen":"2018-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000806888","name":"RESPONSE BIOMEDICAL CORP","url":"/issuer/0000806888","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2016-06-20","last_seen":"2016-06-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"ProNAi Therapeutics Inc","url":"/issuer/0001290149","role":"Director","n_filings":1,"first_seen":"2015-07-21","last_seen":"2015-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001298521","name":"Trubion Pharmaceuticals, Inc","url":"/issuer/0001298521","role":"Director, Officer (President and CEO)","n_filings":2,"first_seen":"2006-10-19","last_seen":"2007-11-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001357522","retrieved_at":"2026-08-24T20:31:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}